ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard.

August 5, 2005